Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Will a Change of Diet Prevent Cancer?

By LabMedica International staff writers
Posted on 30 Jun 2011
Cancer researchers have found that a diet low in carbohydrates and high in protein reduced the risk of developing some types of cancer in a mouse model.

Investigators at the University of British Columbia (Vancouver, Canada) postulated that fast growing cancer cells should require significantly more glucose to grow and thrive than normal cells. More...
Furthermore, they reasoned that restricting glucose intake might slow or prevent tumor growth.

To examine this concept they implanted human tumor cells into various strains of mice, some of which were also growing mouse tumors. The mice were separated into two groups. One group was fed a typical Western diet, containing about 55% carbohydrate, 23% protein, and 22% fat. The second group received a highly modified diet (low CHO diet) that contained 15% carbohydrate, 58% protein, and 26% fat.

Results published in the June 14, 2011, online edition of the journal Cancer Research revealed that both mouse and human tumors grew more slowly in the mice that received the low CHO diet. While there was no significant weight difference between the tumor-bearing mice on the low CHO or Western diets, the low CHO-fed mice exhibited lower blood glucose, insulin, and lactate.

Combining a low CHO diet with chemotherapy increased the effect of the mTOR inhibitor CCI-779 and especially that of the potent anti-inflammatory COX-2 inhibitor Celebrex. In a genetically engineered mouse model of HER-2/neu–induced mammary cancer, tumor penetrance in mice on a Western diet was nearly 50% by the age of one year whereas no tumors were detected in mice on the low CHO diet.

Only one mouse on the Western diet achieved a normal life span, due to cancer-associated deaths, while more than 50% of the mice on the low CHO diet reached or exceeded the normal life span. "This shows that something as simple as a change in diet can have an impact on cancer risk," said senior author Dr. Gerald Krystal, professor of pathology and laboratory medicine at the University of British Columbia.

Related Links:

University of British Columbia




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.